Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $81.60 | Total: $408.00 |
| 1 | 10 | $69.12 | Total: $691.20 |
| 1 | 25 | $58.56 | Total: $1,464.00 |
| 1 | 50 | $49.92 | Total: $2,496.00 |
| 1 | 100 | $43.20 | Total: $4,320.00 |
Overview
Evixapodlin (PD-1PD-L1-IN 7) is a human PD-1PD-L1 proteinprotein interaction inhibitor (IC50: 0.213).Evixapodlin has anticancer and antiviral activities.
Chemical Properties
| Molecular Formula | C34H36Cl2N8O4 |
| Molecular Weight | 691.61 |
| CAS Numbers | 2374856-75-2 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | COc1nc(cnc1CNC[C@@H]1CCC(=O)N1)-c1cccc(c1Cl)-c1cccc(c1Cl)-c1cnc(CNC[C@@H]2CCC(=O)N2)c(OC)n1 |
Storage and Handling
0C Short Term, -20C Long Term
References
Evangelos Aktoudianakis, et al. Pd-1pd-l1 inhibitors. WO2019160882A1.